Neoprobe changes name to Navidea Biopharmaceuticals

12/8/2011 | MedCityNews.com

Neoprobe has announced it has changed its name to Navidea Biopharmaceuticals. The name reflects the company's commitment to "NAVigating IDEAs" that allow for the transition of patient care innovations into the commercial market, the company said. CEO Mark Pykett said the company in January will "reveal a more complete view of the Navidea brand."

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC